Drug
RC-1291 clinical trials
Includes 13 studies of Anamorelin.
- studies test it
- 14
- open now
- 0
- in phase 3
- 6
- first study started
- 2005
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
14 studies that test it; most in 2011 (3)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2006 | 1 |
| 2008 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 8
- Phase 3
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 5
Helsinn Therapeutics (U.S.), Inc (7) · M.D. Anderson Cancer Center (2) · Helsinn Healthcare SA (2) · Tufts University (1) · Lahey Clinic (1) · VA Office of Research and Development (1)
Studies
Open first, then newest update. How each study uses RC-1291 is read from its arms, and is right about nine times in ten.
Testing it · 14
- Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung CancerActive, not recruitingPhase 2/3M.D. Anderson Cancer CenterNCT03637816Written as Anamorelin Hydrochloride
- A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) - 2CompletedPhase 3Helsinn Healthcare SANCT03743064Written as anamorelin HCl
- A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) - 1CompletedPhase 3Helsinn Healthcare SANCT03743051Written as Anamorelin Hydrochloride
- Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid TumorsActive, not recruitingPhase 2M.D. Anderson Cancer CenterNCT03035409Written as Anamorelin Hydrochloride
- Anamorelin Study for Advanced Pancreatic CancerTerminatedPhase 2Lahey ClinicNCT04844970Written as Anamorelin Hydrochloride
- Effect of a Ghrelin Receptor Agonist on Muscle and BoneCompletedPhase 1Tufts UniversityNCT04021706Written as Anamorelin Hydrochloride
- The Role of Ghrelin in Cancer CachexiaTerminatedPhase 2VA Office of Research and DevelopmentNCT01505764Written as Anamorelin HCl
- Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 2)CompletedPhase 3Helsinn Therapeutics (U.S.), IncNCT01387282Written as Anamorelin HCl
- Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1)CompletedPhase 3Helsinn Therapeutics (U.S.), IncNCT01387269Written as Anamorelin HCl
- Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3)CompletedPhase 3Helsinn Therapeutics (U.S.), IncNCT01395914Written as Anamorelin HCl
- Dose Range Study of Anamorelin in Patients With Non-small Cell Lung CancerCompletedPhase 2Helsinn Therapeutics (U.S.), IncNCT00622193Written as anamorelin HCl
- Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/CachexiaCompletedPhase 2Helsinn Therapeutics (U.S.), IncNCT00378131Written as RC-1291
- Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.CompletedPhase 2Helsinn Therapeutics (U.S.), IncNCT00267358Written as RC-1291 HCl
- Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight LossCompletedPhase 2Helsinn Therapeutics (U.S.), IncNCT00219817Written as RC-1291 HCl